¼­ºñ½º¾È³» ȸ¿ø°¡ÀÔ È¸¿øÅ»Åð Áñ°Üã±âµî·Ï
Home Products Company Directory Trade ÇÑÁßÇÕÀÛ Áß±¹ÅõÀÚ
My ChemNet
   ÇöÀçÀ§Ä¡ : Home > Trade
¡¡
¿ÀÆÛ°Ô½ÃÆÇ
Offer to Buy
Offer to Sell







ÀÔ·ÂÀÏÀÚ: 2018-01-18

Á¦¸ñ: LGD-4033 raw SARMs//duosue@chembj.com
  µî·ÏºÐ·ù: Offer to Sell
  ³»¿ë:
Additional_detail: Product Name: 4-((R)-2-((R)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoroMethyl)benzonitrile(LGD-4033) Synonyms: 4-((R)-2-((R)-2,2,2-trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoroMethyl)benzonitrile(LGD-4033);LGD-4033;4-[(2R)-2-[(1R)-2,2,2-Trifluoro-1-hydroxyethyl]-1-pyrrolidinyl]-2-(trifluoromethyl)benzonitrile;4-((R)-2-((R)-2,2,2-Trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-trifluoroMethyl)benzonitrile LGD-4033 CAS: 1165910-22-4 LGD-4033 MF: C14H12F6N2O LGD-4033 MW: 338.2482992 How LGD-4033 works LGD-4033, a novel nonsteroidal, oral selective androgen receptor modulator, binds to the androgen receptor with high affinity and selectivity. It demonstrates anabolic activity in muscles, anti-resorptive and anabolic activity in bones and a robust selectivity for muscle and bone versus prostate and sebaceous glands. LGD-4033 has recently completed a Phase I Multiple Ascending Dose study in healthy volunteers. This randomized, double-blind, placebo-controlled Phase I study established the safety and tolerability up to doses of 22 mg per day.

¿¬¶ôó
´ã ´ç ÀÚ:
mariah
ÀüÈ­¹øÈ£:
15872388127
E - mail:
mariah@ycphar.com

Copyright © 2003-2015 ChemNet.com All Right Reserved.